Mydecine Innovations Group Inc.

Insider profile

Mydecine Innovations Group Inc.'s trades of Pangenomic Health Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
182.96
Quantity 97,957 +49.6%
Value CA$3,418,206
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-03-16 2023-01-02
S Sale
97,957 +49.6%
182.96
CA$3,418,206 		97,957 +49.6% 182.96 CA$3,418,206